Innovating in Drug Delivery at Suono Bio
With Carl Schoellhammer, Founder and COO of Suono Bio
A former student of MIT professor Robert Langer, Carl invented a pill that can inject drugs directly into the gastrointestinal tract. His mPill is a small plastic devices covered with tiny needles and a protective coating that dissolves. The invention, platform technology to deliver therapeutic molecules independent of formulation, helped him win the prestigious Lemelson-MIT Student Prize.
ABOUT SUONO BIO
Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio’s platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic. Suono is a portfolio company of the Rosenman Institute’s VC fund, Medtech Venture Partners.